EirGenix, Inc.
Jens Henneberg has extensive experience in clinical development operations and medical affairs, holding key leadership positions in various pharmaceutical companies. From serving as Deputy Director at Servier to their current role as Senior Director at EirGenix, Jens has been instrumental in overseeing the development programs for various biosimilar candidates and other pharmaceutical products. Henneberg's expertise spans across managing clinical trials, medical monitoring, regulatory communications, and strategic planning, making him a valuable asset in the field of healthcare and pharmaceuticals.
This person is not in any offices
EirGenix, Inc.
2 followers
EirGenix is a contract development and manufacturing organization that provides high-quality and cost-effective service. We support our clients in the development, analytical testing, and cGMP manufacturing of biopharmaceuticals from pre-clinical to commercial manufacturing. EirGenix also specializes in the development of biologics, specializing in the development of biosimilars. Our Services: - Cell Line Development (mammalian/microbial systems) - Process Development and Process Optimization - Analytical Services and Quality Control - cGMP Manufacturing (mammalian/microbial systems) - Taiwan FDA inspected/approved - Japan PMDA inspected/approved - U.S. FDA inspection pending (June 2022) - EMA inspection pending (2022-2023) - Antibody-Drug Conjugate (ADC) Development and Manufacturing